Table 1 Distribution of children by health centre, characteristics of the Morbidity Monitoring study population, and uptake of EPI and IPTi doses

Number children per health centre [n, (%)]

n = 5035

n = 4845

A

486 (4.9)

B

869 (8.9)

C

862 (8.7)

D

999 (10.1)

E

951 (9.6)

F

868 (8.8)

G

840 (8.5)

H

519 (5.2)

I

1198 (12.1)

J

1610 (16.3)

K

678 (6.9)

Demographic characteristics

Sex [n/N, (%)]

Male

2567/5035 (51)

2514/4845 (52)

0.525

Birth order [n/N, (%)]

Singleton

4912/5035(98)

4685/4845 (97)

0.533

Median age at entry into analysis [months, (IQR)]

4 m 3 d (2 m-7 m 24 d)

4 m 12 d (2 m-7 m 27 d)

0.742

Health centre attendance

≥1 health centre attendance [n/N, (%)]

2160/5035 (43)

2067/4845 (43)

0.799

Median number of attendances (IQR)

2 (1-3)

2 (1-3)

0.892

EPI vaccine uptake [n/N, (%)]

DPT dose 2

3618/5035(72)

3181/4845 (66)

0.204

DPT dose 3

2889/4794 (60)

2296/4662 (49)

0.019

Measles vaccine

1609/3208 (50)

1009/3065 (33)

0.003

Median age at EPI vaccinations [months, (IQR)]

DPT dose 2

2 m 18 d(2 m 6 d-3 m 9 d)

2 m 24 d (2 m 9 d-3 m 21 d)

0.435

DPT dose 3

4 m 0 d(3 m 9 d-5 m 0 d)

4 m 3 d (3 m 12 d-5 m 9 d)

0.585

Measles vaccination

9 m 18 d (9 m 6 d-10 m 15 d)

9 m 15 d (9 m 3 d-10 m6 d)

0.099

IPTi uptake [n/N, (%)]

IPTi (at least one dose)

3627/5035 (72)

IPTi (all three doses)

1133/5035 (22)

Median age at IPTi doses [months, (IQR)]

IPTi dose 1

2 m 15 d (2 m 3 d-3 m 6 d)

IPTi dose 2

4 m 0 d (3 m 9 d-5 m 0 d)

IPTi dose 3

9 m 18 d (9 m 3 d-10 m 12 d)